Chris Wood
Chief Investment Strategist, Healthcare & Biotech
Health & Biotech Market veteran
Chris Wood is Mauldin Economics’ chief investment strategist for healthcare and biotech, as well as the chief investment strategist at RiskHedge, an investment research firm focused on understanding and profiting from disruption.
Prior to his career as a professional analyst, Chris played running back for the Cotton Bowl champion Longhorn football team at the University of Texas. His academic background includes bachelor’s degrees in economics and finance, and an MBA with a concentration in finance.
Chris writes Mauldin Economics’ Transformative Age advisory focused on advances in the science of age reversal.
Premium Publications
Transformative Age
Your Trusted Source for the Latest Longevity and Biotech Breakthroughs
Stay ahead in longevity and biotech with updates, investment guidance, a curated portfolio, expert calls, and a supportive community.
PRAISE FOR TRANSFORMATIVE AGE:
I think we finally have the right team to turn my passion for longevity and biotech into something truly groundbreaking.”